| 10-Q |
Report
| Data |
10-Q |
Aug 13, 2024 |
Jun 30, 2024 |
| 8-K |
Report
| Data |
8-K |
Aug 13, 2024 |
Aug 13, 2024 |
| 8-K |
Report
| Data |
8-K |
Jun 13, 2024 |
Jun 11, 2024 |
| 10-Q |
Report
| Data |
10-Q |
May 10, 2024 |
Mar 31, 2024 |
| 8-K |
Report
| Data |
8-K |
May 10, 2024 |
May 10, 2024 |
| 8-K |
Report
| Data |
8-K |
May 10, 2024 |
May 10, 2024 |
| 8-K |
Report
| Data |
8-K |
Apr 17, 2024 |
Apr 11, 2024 |
| 8-K |
Report
| Data |
8-K |
Mar 27, 2024 |
Mar 27, 2024 |
| 10-K |
Report
| Data |
10-K |
Mar 8, 2024 |
Dec 31, 2023 |
| 8-K |
Report
| Data |
8-K |
Mar 8, 2024 |
Mar 8, 2024 |
| 8-K |
Report
| Data |
8-K |
Feb 16, 2024 |
Feb 12, 2024 |
| 8-K |
Report
| Data |
8-K |
Dec 6, 2023 |
Dec 1, 2023 |
| 8-K |
Report
| Data |
8-K |
Nov 27, 2023 |
Nov 20, 2023 |
| 10-Q |
Report
| Data |
10-Q |
Nov 13, 2023 |
Sep 30, 2023 |
| 8-K |
Report
| Data |
8-K |
Nov 13, 2023 |
Nov 13, 2023 |
| 8-K |
Report
| Data |
8-K |
Nov 2, 2023 |
Nov 2, 2023 |
| 8-K |
Report
| Data |
8-K |
Nov 1, 2023 |
Oct 30, 2023 |
| 8-K |
Report
| Data |
8-K |
Sep 27, 2023 |
Sep 25, 2023 |
| 8-K |
Report
| Data |
8-K |
Aug 11, 2023 |
Aug 10, 2023 |
| 10-Q |
Report
| Data |
10-Q |
Aug 11, 2023 |
Jun 30, 2023 |
| 8-K |
Report
| Data |
8-K |
Aug 1, 2023 |
Aug 1, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 14, 2023 |
Jun 8, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 9, 2023 |
Jun 6, 2023 |
| 8-K |
Report
| Data |
8-K |
Jun 2, 2023 |
Jun 1, 2023 |
| 10-Q |
Report
| Data |
10-Q |
May 15, 2023 |
Mar 31, 2023 |
| 8-K |
Report
| Data |
8-K |
May 15, 2023 |
May 15, 2023 |
| 8-K |
Report
| Data |
8-K |
Apr 21, 2023 |
Apr 19, 2023 |
| 10-K |
Report
| Data |
10-K |
Mar 30, 2023 |
Dec 31, 2022 |
| 8-K |
Report
| Data |
8-K |
Mar 30, 2023 |
Mar 30, 2023 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2023 |
|
| 8-K |
Report
| Data |
8-K |
Jan 25, 2023 |
Jan 25, 2023 |
| 8-K |
Report
| Data |
8-K |
Dec 6, 2022 |
Dec 6, 2022 |
| 8-K |
Report
| Data |
8-K |
Nov 7, 2022 |
Nov 6, 2022 |
| 10-Q |
Report
| Data |
10-Q |
Nov 4, 2022 |
Sep 30, 2022 |
| 8-K |
Report
| Data |
8-K |
Nov 4, 2022 |
Nov 4, 2022 |
| 8-K |
Report
| Data |
8-K |
Oct 14, 2022 |
Oct 14, 2022 |
| 10-Q |
Report
| Data |
10-Q |
Aug 12, 2022 |
Jun 30, 2022 |
| 8-K |
Report
| Data |
8-K |
Aug 12, 2022 |
Aug 12, 2022 |
| 8-K |
Report
| Data |
8-K |
Jun 17, 2022 |
Jun 13, 2022 |
| 8-K |
Report
| Data |
8-K |
Jun 10, 2022 |
Jun 10, 2022 |
| 8-K |
Report
| Data |
8-K |
May 19, 2022 |
May 19, 2022 |
| SC 13G |
Report
|
SCHEDULE 13G |
May 17, 2022 |
|
| 10-Q |
Report
| Data |
10-Q |
May 13, 2022 |
Mar 31, 2022 |
| 8-K |
Report
| Data |
8-K |
May 13, 2022 |
May 13, 2022 |
| 8-K |
Report
| Data |
8-K |
Apr 28, 2022 |
Apr 28, 2022 |
| 8-K |
Report
| Data |
8-K |
Mar 29, 2022 |
Mar 29, 2022 |
| 10-K |
Report
| Data |
10-K |
Mar 24, 2022 |
Dec 31, 2021 |
| 8-K |
Report
| Data |
8-K |
Mar 24, 2022 |
Mar 24, 2022 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2022 |
|
| SC 13G/A |
Report
|
AMENDMENT TO SC 13G |
Feb 14, 2022 |
|
| 8-K |
Report
| Data |
8-K |
Jan 31, 2022 |
Jan 31, 2022 |
| 8-K |
Report
| Data |
8-K |
Jan 31, 2022 |
Jan 31, 2022 |
| SC 13G/A |
Report
|
OCUPHIRE PHARMA, INC. |
Jan 18, 2022 |
|
| 8-K |
Report
| Data |
8-K |
Jan 5, 2022 |
Jan 5, 2022 |
| 8-K |
Report
| Data |
8-K |
Nov 15, 2021 |
Nov 12, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Nov 12, 2021 |
Sep 30, 2021 |
| 10-Q |
Report
| Data |
10-Q |
Aug 12, 2021 |
Jun 30, 2021 |
| 8-K |
Report
|
8-K |
Aug 12, 2021 |
Aug 12, 2021 |
| 8-K |
Report
|
8-K |
Jun 30, 2021 |
Jun 30, 2021 |
| 8-K |
Report
|
8-K |
Jun 23, 2021 |
Jun 16, 2021 |
| 8-K |
Report
|
8-K |
Jun 8, 2021 |
Jun 7, 2021 |
| 8-K/A |
Report
|
8-K/A |
Jun 7, 2021 |
Jun 4, 2021 |
| 8-K |
Report
|
FORM 8-K |
Jun 4, 2021 |
Jun 4, 2021 |
| 10-Q |
Report
| Data |
10-Q |
May 7, 2021 |
Mar 31, 2021 |
| 8-K |
Report
|
8-K |
May 7, 2021 |
May 7, 2021 |
| 8-K |
Report
|
8-K |
Apr 12, 2021 |
Apr 9, 2021 |
| SC 13G |
Report
|
SC 13G |
Mar 26, 2021 |
|
| SC 13G |
Report
|
SC 13G |
Mar 17, 2021 |
|
| 8-K |
Report
|
FORM 8-K |
Mar 15, 2021 |
Mar 15, 2021 |
| 8-K |
Report
|
8-K |
Mar 11, 2021 |
Mar 10, 2021 |
| 8-K |
Report
|
FORM 8-K |
Mar 11, 2021 |
Mar 11, 2021 |
| 10-K |
Report
| Data |
10-K |
Mar 11, 2021 |
Dec 31, 2020 |
| SC 13G/A |
Report
|
AMENDMENT TO FORM SC 13G |
Feb 16, 2021 |
|
| 8-K |
Report
|
CURRENT REPORT |
Feb 4, 2021 |
Feb 3, 2021 |
| SC 13G/A |
Report
|
OCUPHIRE PHARMA, INC. |
Feb 2, 2021 |
|
| 8-K |
Report
|
8-K |
Jan 6, 2021 |
Jan 6, 2021 |
| 8-K/A |
Report
|
8-K/A |
Dec 30, 2020 |
Nov 5, 2020 |
| 8-K |
Report
|
8-K |
Nov 25, 2020 |
Nov 19, 2020 |
| 8-K |
Report
|
8-K |
Nov 17, 2020 |
Nov 11, 2020 |
| SC 13G |
Report
|
THE SCHEDULE 13G |
Nov 16, 2020 |
|
| SC 13G |
Report
|
ACQUISITION OF BENEFICIAL OWNERSHIP |
Nov 16, 2020 |
|
| SC 13G |
Report
|
EMPERY ASSET MANAGEMENT, LP |
Nov 12, 2020 |
|
| 8-K |
Report
|
8-K |
Nov 6, 2020 |
Nov 6, 2020 |
| 8-K |
Report
|
8-K |
Nov 3, 2020 |
Nov 2, 2020 |
| 10-Q |
Report
| Data |
10-Q |
Oct 29, 2020 |
Sep 30, 2020 |
| 8-K |
Report
|
8-K |
Oct 9, 2020 |
Oct 8, 2020 |
| 8-K |
Report
|
8-K |
Sep 11, 2020 |
Sep 10, 2020 |
| 8-K |
Report
|
8-K |
Sep 2, 2020 |
Sep 1, 2020 |
| 10-Q |
Report
| Data |
10-Q |
Aug 14, 2020 |
Jun 30, 2020 |
| SC 13G |
Report
|
|
Aug 10, 2020 |
|
| 8-K |
Report
|
8-K |
Aug 3, 2020 |
Jul 31, 2020 |
| 8-K |
Report
|
FORM 8-K |
Jul 1, 2020 |
Jun 29, 2020 |
| 8-K |
Report
|
8-K |
Jun 19, 2020 |
Jun 17, 2020 |
| 10-Q |
Report
| Data |
10-Q |
May 7, 2020 |
Mar 31, 2020 |
| 10-K/A |
Report
|
10-KA |
Apr 29, 2020 |
Dec 31, 2019 |
| 8-K |
Report
|
8-K |
Apr 9, 2020 |
Apr 7, 2020 |
| 8-K |
Report
|
8-K |
Mar 16, 2020 |
Mar 10, 2020 |
| 10-K |
Report
| Data |
10-K |
Feb 21, 2020 |
Dec 31, 2019 |
| 8-K |
Report
|
8-K |
Feb 10, 2020 |
Feb 8, 2020 |
| 10-Q |
Report
| Data |
10-Q |
Nov 6, 2019 |
Sep 30, 2019 |
| 8-K |
Report
|
8-K |
Aug 29, 2019 |
Aug 29, 2019 |
| 8-K |
Report
|
8-K |
Aug 29, 2019 |
Aug 24, 2019 |
| 10-Q |
Report
| Data |
10-Q |
Aug 7, 2019 |
Jun 30, 2019 |
| 8-K |
Report
|
8-K |
Aug 7, 2019 |
Aug 7, 2019 |
| 8-K |
Report
|
8-K |
Jun 7, 2019 |
Jun 6, 2019 |
| 8-K |
Report
|
8-K |
May 29, 2019 |
May 28, 2019 |
| 10-Q |
Report
| Data |
10-Q |
May 10, 2019 |
Mar 31, 2019 |
| 8-K |
Report
|
8-K |
Apr 16, 2019 |
Apr 16, 2019 |
| 8-K |
Report
|
8-K |
Apr 12, 2019 |
Apr 12, 2019 |
| 8-K |
Report
|
8-K |
Mar 26, 2019 |
Mar 26, 2019 |
| 8-K |
Report
|
8-K |
Mar 11, 2019 |
Mar 11, 2019 |
| 10-K |
Report
| Data |
10-K |
Mar 7, 2019 |
Dec 31, 2018 |
| 8-K |
Report
|
8-K |
Mar 6, 2019 |
Mar 4, 2019 |
| 8-K |
Report
|
8-K |
Mar 1, 2019 |
Feb 27, 2019 |
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2019 |
|
| SC 13G/A |
Report
|
SC 13G/A |
Feb 14, 2019 |
|
| SC 13G |
Report
|
|
Feb 5, 2019 |
|
| 8-K |
Report
|
8-K |
Jan 25, 2019 |
Jan 23, 2019 |
| 8-K |
Report
|
8-K |
Jan 22, 2019 |
Jan 22, 2019 |
| 8-K |
Report
|
8-K |
Dec 3, 2018 |
Nov 29, 2018 |
| 8-K |
Report
|
8-K |
Nov 16, 2018 |
Nov 13, 2018 |
| 10-Q |
Report
| Data |
10-Q |
Nov 2, 2018 |
Sep 30, 2018 |
| SC 13G |
Report
|
SC 13G |
Oct 29, 2018 |
|
| SC 13G |
Report
|
SC 13G |
Oct 26, 2018 |
|
| 8-K |
Report
|
8-K |
Oct 19, 2018 |
Oct 16, 2018 |
| 8-K |
Report
|
8-K |
Aug 30, 2018 |
Aug 30, 2018 |
| 8-K |
Report
|
8-K |
Aug 21, 2018 |
Aug 16, 2018 |
| 10-Q |
Report
| Data |
10-Q |
Aug 3, 2018 |
Jun 30, 2018 |
| 8-K |
Report
|
8-K |
Jun 28, 2018 |
Jun 27, 2018 |
| 8-K |
Report
|
8-K |
Jun 18, 2018 |
Jun 14, 2018 |
| 10-Q |
Report
| Data |
10-Q |
May 4, 2018 |
Mar 31, 2018 |
| 8-K |
Report
|
8-K |
Apr 18, 2018 |
Apr 18, 2018 |
| 10-K |
Report
| Data |
10-K |
Mar 9, 2018 |
Dec 31, 2017 |
| 8-K |
Report
|
8-K |
Feb 8, 2018 |
Feb 5, 2018 |
| 8-K |
Report
|
8-K |
Jan 19, 2018 |
Jan 18, 2018 |
| 8-K |
Report
|
8-K |
Jan 4, 2018 |
Jan 2, 2018 |
| 8-K |
Report
|
8-K |
Dec 21, 2017 |
Dec 15, 2017 |
| 8-K |
Report
|
8-K |
Dec 12, 2017 |
Dec 11, 2017 |
| 10-Q |
Report
| Data |
10-Q |
Nov 3, 2017 |
Sep 30, 2017 |
| 8-K |
Report
|
8-K |
Oct 17, 2017 |
Oct 17, 2017 |
| 8-K |
Report
|
8-K |
Oct 13, 2017 |
Oct 12, 2017 |
| 8-K |
Report
|
8-K |
Sep 1, 2017 |
Aug 29, 2017 |
| 10-Q |
Report
| Data |
10-Q |
Aug 4, 2017 |
Jun 30, 2017 |
| 8-K |
Report
|
8-K |
Jun 12, 2017 |
Jun 12, 2017 |
| 8-K |
Report
|
8-K |
Jun 7, 2017 |
Jun 5, 2017 |
| 8-K |
Report
|
8-K |
May 5, 2017 |
May 5, 2017 |
| 10-Q |
Report
| Data |
10-Q |
May 3, 2017 |
Mar 31, 2017 |
| 8-K |
Report
|
8-K |
Apr 13, 2017 |
Apr 11, 2017 |
| 10-K |
Report
| Data |
REXAHN PHARMACEUTICALS 10-K 12-31-2016 |
Feb 24, 2017 |
Dec 31, 2016 |
| SC 13G/A |
Report
|
REXAHN PHARMACEUTICALS, INC. |
Jan 17, 2017 |
|
| SC 13G/A |
Report
|
SABBY 13G-A RNN 1.10.17 |
Jan 10, 2017 |
|
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 11-22-2016 |
Nov 25, 2016 |
Nov 22, 2016 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC 10-Q 9-30-2016 |
Nov 4, 2016 |
Sep 30, 2016 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 9-19-2016 |
Sep 20, 2016 |
Sep 19, 2016 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 9-14-2016 |
Sep 14, 2016 |
Sep 14, 2016 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 9-12-2016 |
Sep 12, 2016 |
Sep 12, 2016 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2016 |
Aug 5, 2016 |
Jun 30, 2016 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 7-6-2016 |
Jul 11, 2016 |
Jul 6, 2016 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 6-9-2016 |
Jun 10, 2016 |
Jun 9, 2016 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2016 |
May 6, 2016 |
Mar 31, 2016 |
| 10-K |
Report
| Data |
REXAHN PHARMACEUTICALS, INC 10-K 12-31-2015 |
Mar 14, 2016 |
Dec 31, 2015 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 3-2-2016 |
Mar 2, 2016 |
Mar 2, 2016 |
| SC 13G |
Report
|
SABBY 13G RNN 2.29.16 |
Feb 29, 2016 |
|
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 2-26-2016 |
Feb 26, 2016 |
Feb 26, 2016 |
| SC 13G/A |
Report
|
REXAHN PHARMACEUTICALS, INC. |
Jan 19, 2016 |
|
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 11-12-2015 |
Nov 12, 2015 |
Nov 12, 2015 |
| SC 13G |
Report
|
REXAHN PHARMACEUTICALS, INC. |
Nov 10, 2015 |
|
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 11-5-2015 |
Nov 6, 2015 |
Nov 5, 2015 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 11-5-2015 |
Nov 5, 2015 |
Nov 5, 2015 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2015 |
Nov 2, 2015 |
Sep 30, 2015 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 9-28-2015 |
Sep 28, 2015 |
Sep 28, 2015 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 9-10-2015 |
Sep 10, 2015 |
Sep 10, 2015 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2015 |
Aug 7, 2015 |
Jun 30, 2015 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 7-17-2015 |
Jul 17, 2015 |
Jul 17, 2015 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 6-4-2015 |
Jun 5, 2015 |
Jun 4, 2015 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2015 |
May 8, 2015 |
Mar 31, 2015 |
| 10-K |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-K 12-31-2014 |
Mar 16, 2015 |
Dec 31, 2014 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 2-2-2015 |
Feb 4, 2015 |
Feb 2, 2015 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 12-2-2014 |
Dec 3, 2014 |
Dec 2, 2014 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2014 |
Nov 12, 2014 |
Sep 30, 2014 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 10-1-2014 |
Oct 3, 2014 |
Oct 1, 2014 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2014 |
Aug 13, 2014 |
Jun 30, 2014 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 6-9-2014 |
Jun 9, 2014 |
Jun 9, 2014 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 3-31-2014 |
May 14, 2014 |
Mar 31, 2014 |
| 10-K |
Report
| Data |
REXAHN PHARMACEUTICALS, INC 10-K 12-31-2013 |
Mar 21, 2014 |
Dec 31, 2013 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 2-26-2014 |
Mar 3, 2014 |
Feb 26, 2014 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 1-21-2014 |
Jan 21, 2014 |
Jan 21, 2014 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 1-14-2014 |
Jan 15, 2014 |
Jan 14, 2014 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 1-14-2014 |
Jan 14, 2014 |
Jan 14, 2014 |
| SC 13G/A |
Report
|
SABBY 13G-A RNN 01.07.14 |
Jan 7, 2014 |
|
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 9-30-2013 |
Nov 13, 2013 |
Sep 30, 2013 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC. 8-K 10-10-2013 |
Oct 16, 2013 |
Oct 10, 2013 |
| SC 13D/A |
Report
|
AHN CHANG HO SC 13D A NO 5 10-7-2013 (REXAHN PHARMACEUTICALS, INC) |
Oct 9, 2013 |
|
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 8-25-2013 |
Aug 29, 2013 |
Aug 25, 2013 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS INC 10-Q 6-30-2013 |
Aug 12, 2013 |
Jun 30, 2013 |
| 8-K |
Report
|
FORM 8-K |
Jul 24, 2013 |
Jul 23, 2013 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 7-15-2013 |
Jul 15, 2013 |
Jul 15, 2013 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS 8-K 6-10-2013 |
Jun 11, 2013 |
Jun 10, 2013 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC 10-Q 3-31-2013 |
May 9, 2013 |
Mar 31, 2013 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 3-25-2013 |
Mar 29, 2013 |
Mar 25, 2013 |
| 10-K |
Report
| Data |
REXAHN PHARMACEUTICALS INC 10-K 12-31-2012 |
Mar 22, 2013 |
Dec 31, 2012 |
| SC 13G/A |
Report
|
SABBY 13G-A RNN 01.28.13 |
Jan 28, 2013 |
|
| 8-K |
Report
|
FORM 8-K |
Jan 22, 2013 |
Jan 22, 2013 |
| 8-K |
Report
|
FORM 8-K |
Dec 13, 2012 |
Dec 7, 2012 |
| 8-K |
Report
|
FORM 8-K |
Dec 10, 2012 |
Dec 10, 2012 |
| 8-K |
Report
|
FORM 8-K |
Dec 4, 2012 |
Dec 4, 2012 |
| SC 13G |
Report
|
SABBY 13G RNN 12.4.12 |
Dec 4, 2012 |
|
| 8-K |
Report
|
FORM 8-K |
Nov 30, 2012 |
Nov 29, 2012 |
| 8-K |
Report
|
FORM 8-K |
Nov 27, 2012 |
Nov 27, 2012 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC 10-Q 9-30-2012 |
Nov 8, 2012 |
Sep 30, 2012 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC 10-Q 6-30-2012 |
Aug 8, 2012 |
Jun 30, 2012 |
| SC 13D/A |
Report
|
REXAHN PHARMACEUTICALS, INC SC 13DA 7-20-2012 (AHN) |
Jul 20, 2012 |
|
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 6-18-2012 |
Jun 21, 2012 |
Jun 18, 2012 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS, INC. 10-Q 03-31-2012 |
May 9, 2012 |
Mar 31, 2012 |
| 10-K |
Report
| Data |
REXAHN PHARMACEUTICALS, INC 10-K 12-31-2011 |
Mar 16, 2012 |
Dec 31, 2011 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 1-17-2012 |
Jan 17, 2012 |
Jan 17, 2012 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS 10-Q 9-30-2011 |
Nov 9, 2011 |
Sep 30, 2011 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 11-4-2011 |
Nov 4, 2011 |
Nov 4, 2011 |
| 10-Q |
Report
| Data |
REXAHN PHARMACEUTICALS INC 10-Q 6-30-2011 |
Aug 9, 2011 |
Jun 30, 2011 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 6-6-2011 |
Jun 10, 2011 |
Jun 6, 2011 |
| SC 13D/A |
Report
|
REXAHN PHARMACEUTICALS INC SC 13D A 5-31-2011 |
Jun 3, 2011 |
|
| SC 13D/A |
Report
|
REXAHN PHARMACEUTICALS SC 13D/A 5-18-2011 |
May 20, 2011 |
|
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS 10-Q 3-31-2011 |
May 9, 2011 |
Mar 31, 2011 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 3-23-2011 |
Mar 30, 2011 |
Mar 23, 2011 |
| 10-K/A |
Report
|
REXAHN PHARMACEUTICALS, INC FORM 10-K/A 12-31-2010 |
Mar 23, 2011 |
Dec 31, 2010 |
| 10-K |
Report
|
REXAHN PHARMACEUTICALS, INC 10-K 12-31-2010 |
Mar 16, 2011 |
Dec 31, 2010 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 3-15-2011 |
Mar 16, 2011 |
Mar 15, 2011 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 3-7-2011 |
Mar 7, 2011 |
Mar 7, 2011 |
| SC 13G |
Report
|
SC 13G |
Jan 28, 2011 |
|
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 1-19-2011 |
Jan 20, 2011 |
Jan 19, 2011 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS 10-Q 9-30-2010 |
Nov 15, 2010 |
Sep 30, 2010 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS 8-K 9-9-2010 |
Sep 13, 2010 |
Sep 9, 2010 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS, INC 8-K 9-9-2010 |
Sep 10, 2010 |
Sep 9, 2010 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS, INC. 10-Q 6-30-2010 |
Aug 16, 2010 |
Jun 30, 2010 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 6-30-2010 |
Jul 1, 2010 |
Jun 30, 2010 |
| 8-K |
Report
|
REXAHN PARMACEUTICALS 8-K 6-27-2010 |
Jun 29, 2010 |
Jun 27, 2010 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 6-14-2010 |
Jun 16, 2010 |
Jun 14, 2010 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS INC 10-Q 3-31-2010 |
May 21, 2010 |
Mar 31, 2010 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS 8-K 4-13-2010 |
Apr 16, 2010 |
Apr 13, 2010 |
| 10-K |
Report
|
REXAHN PHARMACEUTICALS 10-K 12-31-2009 |
Mar 31, 2010 |
Dec 31, 2009 |
| 8-K |
Report
|
REXAHN PHARMACEUTICALS INC 8-K 3-24-2010 |
Mar 26, 2010 |
Mar 24, 2010 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS 10-Q 9-30-2009 |
Nov 16, 2009 |
Sep 30, 2009 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS 10-Q 6-30-2009 |
Aug 10, 2009 |
Jun 30, 2009 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS INC 10-Q 3-31-2009 |
May 11, 2009 |
Mar 31, 2009 |
| 10-K |
Report
|
REXAHN PARMACEUTICAL INC 10-K 12-31-2008 |
Mar 16, 2009 |
Dec 31, 2008 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS INC 10-Q 9-30-2008 |
Nov 14, 2008 |
Sep 30, 2008 |
| 10-Q |
Report
|
REXAHN PARMACEUTICALS 10Q 6-30-2008 |
Aug 14, 2008 |
Jun 30, 2008 |
| 10-Q |
Report
|
REXAHN PHARMACEUTICALS INC 10-Q 3-31-2008 |
May 15, 2008 |
Mar 31, 2008 |